09639400600

Saturday To Thursday 9 am To 6 pm
butwwbuttw

Medicines

  Refine Search
Filter on Brand
Health Concern
  Featured
  Specials


Cardipin 5 mg tab

Cardipin 5 mg tab

Cardipin 5 mg tab..

Tk.5.00/=

  0 отзывов

Cardipin PLUS 5/50

Cardipin PLUS 5/50

Cardipin PLUS 5/50..

Tk.6.00/=

  0 отзывов

Cardopril 25

Cardopril 25

Cardopril 251. What is and what it is used for?Cardopril (Captopril) is the first of a new class of antihypertensive agents a highly specific inhibitor of angiotensin converting enzyme. It is also effective in the management of heart failure. Cardopril is designated chemically as (1-[(2S)-3 Mercapto-2 methyl propionyl-L-proline.) Cardopril is available in potencies of 25 mg & 50 mg as scored tablet for oral administration. Cardopril inhibits angiotenin converting enzyme (ACE) involved in the conversion of angiotensin I to angiotensin II and may also reduce the degradation of bradykinin. Cardopril produces a reduction in total peripheral resistance and in patients with congestive heart failure & reduction in both preload and post load. Following oral administration, Cardopril produces a maximal effect within 1 to 2 hours, although the full effect may not develop for several weeks during chronic dosing. The duration of action is dose dependent and may persist for 6 to 12 hours.Cardopril is used for mild to moderate hypertension as an adjunct to thiazide therapy in patients who have not responded effectively to thiazide treatment alone. Severe hypertension where standard therapy has failed. Cardopril is effective alone and in combination with other antihypertensive agents especially thiazide type diuretics. The blood pressure lowering effect of Cardopril and thiazides are approximately additive. It is also used as an adjunct to the treatment of severe congestive heart failure.2. Before you take Cardopril®Do not take this medicine and tell your doctor if:A history of previous hypersensitivity to Captopril is present. Do not take this medicine if the above applies to you. If you are not sure, talk to your doctor before taking Cardopril.Take special care with CardoprilCardopril should be used with great caution in patients with impaired renal function particularly if reno vascular disease is present or suspected and in patients with collagen vascular disorders such as systemic lupus erythematosus or scleroderma. Renal function should be assessed in all patients prior to administration of Cardopril. Patients with existing renal diseases or taking high doses of Captopril should be monitored regularly for proteinuria. Regular white blood cell counts should be made during the initial stage of therapy particularly in patients with collagen vascular disorders or impaired renal function and in patients receiving immunosuppressive therapy. Cardopril should not be used in patients with aortic stenosis or outflow tract obstruction. Patients with congestive heart failure and patients who are likely to be salt or water depleted due to concomitant treatment with diuretics or dialysis may experience symptomatic hypertension during the initial stages of Cardopril therapy, this may be minimized by starting with a low dose, preferably on retiring.Taking other medicinesDiuretics potentiate the antihypertensive effectiveness of Cardopril. Potassium scanning diuretics (triameterene, amiloride and spironolactone) or potassium supplements may cause significant increase in serum potassium. Cardopril has been reported to act synergistically with peripheral vasodilators such as minimal. Concomitant therapy with indomethacin and possibly other nonsteroidal anti-inflammatory drugs may reduce the antihypertensive effect of Cardopril. Caution should be exercised in prescribing Cardopril for patients receiving concomitant therapy with immunosuppressant, procainamide alopurinal and other drugs known to cause neutropenia especially in patients with impaired renal function.Pregnancy and breast-feedingThere are no adequate and well controlled studies in pregnant women. Cardopril should be used during pregnancy or for patient likely to become pregnant only if the potential benefit justifies a potential risk to the fetus. Cardopril is excreted in breast milk & should not be used in nursing mothers.3. How to take Cardopril®?Rapid absorption occurs after administration of therapeutic dose of Cardopril & peak blood level is achieved at about one hour. Presence of food in gastrointestinal tract reduces absorption by 30-40 percent. Cardopril therefore SHOULD BE GIVEN ONE HOUR BEFORE MEALS.Hypertension: Treatment with Cardopril should be at the lowest effective dose, which should be titrated according to the need of the patients.Mild to moderate hypertension: In mild to moderate hypertension, Captopril therapy should be used as an adjunct to thiazide therapy. Starting dose is 12.5 mg twice daily. The usual maintenance dose is 25 mg twice daily, which can be increased incrementally, at 2-4 weeks intervals, until a satisfactory response is achieved to a maximum of 50 mg twice daily.Severe hypertension: Starting dose is 12.5 mg twice daily and can be increased incrementally to a maximum of 50 mg thrice daily.Cardopril should be used together with other antihypertensive agent but the dose of those should be individually titrated.A daily dose ..

Tk.3.01/=

  0 отзывов

Cavic C PLUS Tab 12's pack

Cavic C PLUS Tab 12's pack

Cavic C PLUS Tab 12's packPresentationCavic-C Plus effervescent tablet: Each tablet contains Calcium Lactate Gluconate USP 1000 mg, Calcium Carbonate BP 327 mg, Ascorbic acid (Vitamin-C) BP 500 mg and Vitamin-D3 4 mg (eq. to Colecalciferol BP 400 IU).Indications•As an adjunct to specific therapy for osteoporosis•Increased demand for Calcium, Vitamin-C and Vitamin-D such as pregnancy, lactation, period of rapid growing (in childhood, addoloscence) and in old age•In osteomalacia•The prevention and treatment of Calcium deficiency/Vitamin-D deficiency especially in the housebound and hospitalized elderly subjects•As adjuvant in cold and influenza•Postmenopausal syndromes•Premenstrual symptoms•In high body temperatures•As alkalizing agent in conditions with systemic acidosis.Dosage & AdministrationDosage of Cavic-C Plus should be individualized based on the demands in age, sex and various physiological (pregnancy & lactation) & disease conditions. In general the dosage is-Adults and children above 7 years: 1 Cavic-C Plus effervescent tablet dailyChildren 3-7 years: Half Cavic-C Plus effervescent tablet dailySide EffectsThe use of Calcium supplements has rarely given rise to mild gastrointestinal disturbances, such as constipation, flatulence, nausea, gastric pain and diarrhoea. Following administration of Vitamin-D supplements occasional skin rash has been reported. Hypercalciuria, and in rare cases hypercalcaemia have been seen in long-term treatment with Vitamin-D at high doses.PrecautionsPatients with mild to moderate renal failure or mild hypercalciuria should be supervised carefully. Periodic checks of plasma Calcium levels and urinary Calcium excretion should be made in patients with mild to moderate renal failure or mild hypercalciuria. In patients with a history of renal stones urinary Calcium excretion should be measured to exclude hypercalciuria. With long-term treatment it is advisable to monitor serum and urinary Calcium levels and kidney function, and reduce or stop treatment temporarily if urinary Calcium exceeds 7.5 mmol/24 hours. Allowances should be made for Calcium and Vitamin-D supplements from other sources.Use in Pregnancy & LactationDuring pregnancy and lactation treatment with Cavic-C Plus should always be under the direction of a physician. During pregnancy and lactation, requirements for Calcium and Vitamin-D are increased but in deciding on the required supplementation allowances should be made for availability of these agents from other sources. Overdoses of Vitamin-D have shown teratogenic effects in pregnant animals. Vitamin-D and its metabolites pass into the breast milk.Over DoseThe most serious consequence of acute or chronic overdose is hypercalcaemia due to Vitamin-D toxicity. Symptoms include nausea, vomiting, polyuria, and constipation. Chronic overdoses can lead to vascular and organ calcification as a result of hypercalcaemia. Treatment should consist of stopping all intakes of calcium and Vitamin-D and rehydration.Commercial PackCavic-C Plus effervescent tablet: Each tube contains 10 effervescent tablets...

Tk.120.00/=

  0 отзывов

Cavic C Tab

Cavic C Tab

Cavic C Tab..

Tk.100.00/=

  0 отзывов

CCB 5 Tab

CCB 5 Tab

CCB 5 Tab..

Tk.3.01/=

  0 отзывов

Cdens Tab

Cdens Tab

Cdens Tab..

Tk.12.00/=

  0 отзывов

Ceclofen 100 mg Tablet

Ceclofen 100 mg Tablet

Ceclofen..

Tk.4.00/=

  0 отзывов

Ceevit 250 mg Tablet

Ceevit 250 mg Tablet

Indication:Scurvy, pregnancy, lactation, infection, trauma, burns, cold exposure, following surgery, fever, stress, peptic ulcer, cancer, methaemoglobinaemia haematuria, dental caries, pyorrhea, acne, infertility, atherosclerosis, fractures, leg ulcers, hay fever, vascular thrombosis prevention, levodopa toxicity, succinyl-choline toxicity,arsenic toxicity etc.Dosage & Administration:1-2 tablets daily.Preparation:CeevitTM: Box containing 25 x 10 tablets in strip pack...

Tk.2.00/=

  0 отзывов

Cefaclav 125 Tab

Cefaclav 125 Tab

Cefaclav 125 TabDescriptionCefuroxime is one of the bactericidal second generation cephalosporin antibiotics, which is active against a wide range of Gram-positive and Gram-negative susceptible organisms including many beta-lactamase producing strains. It is indicated for the treatment of infections caused by sensitive bacteria.Clavulanic acid has a similar structure to the beta-lactam antibiotics but binds irreversibly to the beta-lactamase enzymes.The presence of clavulanic acid in Cefaclav formulations protects Cefuroxime from degradation by beta-lactamase enzymes and effectively extends the antibacterial spectrum of Cefuroxime to include many bacteria normally resistant to Cefuroxime and other cephalosporins.IndicationsPharyngitis/tonsillitis caused by Streptococcus pyogenesAcute bacterial otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase-producing strains), Moraxella Catarrhalis (including beta-lactamase-producing strains) or Streptococcus pyogenesAcute bacterial maxillary sinusitis caused by Streptococcus pneumoniae or Haemophilus influenzae (non-beta-lactamase-producing strains only)Lower respiratory tract infections including pneumoniae, caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase-producing strains), Klebsiella spp., Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, Escherichia coliAcute bacterial exacerbations of chronic bronchitis and secondary bacterial infections of acute bronchitis caused by Streptococcus penumoniae, Haemophilus influenzae (beta-lactamase negative strains) or Haemophilus parainfluenzae (beta-lactamase negative strains)Skin and Skin-Structure Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, Escherichia coli, Klebsiella spp. and Enterobacter spp.Urinary tract infections caused by Escherichia coli or Klebsiella pneumoniaeBone and Joint Infections caused by Staphylococcus aureus (penicillinase and non-penicillinase producing strains)Gonorrhea: Uncomplicated and disseminated gonococcal infections due to Neisseria gonorrhoeae (penicillinase- and non-penicillinase-producing strains) in both males and femalesEarly Lyme disease (erythema migrans) caused by Borrelia burgdorferiSepticemia caused by Staphylococcus aureus (penicillinase and non-penicillinase producing strains), Streptococcus pneumoniae, Escherichia coli, Haemophilus influenzae (including ampicillin-resistant strains), and Klebsiella spp.Meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including ampicillin resistant strains), Neisseria meningitidis and Staphylococcus aureus (penicillinase and non-penicillinase producing strains)Switch therapy (injectable to oral) after surgery when patient’s condition is improved.Dosage & AdministrationAdolescents & adults:Pharyngitis or Tonsillitis: 250 mg twice daily 5-10 daysAcute bacterial maxillary sinusitis: 250 mg twice daily 10 daysAcute bacterial exacerbation of chronic bronchitis: 250-500 mg twice daily 10 daysSecondary bacterial infections of acute bronchitis: 250-500 mg twice daily 5-10 daysCommunity acquired pneumonia: 250-500 mg twice daily 5-10 daysUncomplicated skin & skin-structure infections: 250-500 mg twice daily 10 daysMDR Typhoid fever: 500 mg twice daily 10-14 daysUncomplicated urinary tract infection: 250 mg twice daily 7-10 daysUncomplicated gonorrhea: 1000 mg single doseLyme disease: 500 mg twice daily 20 daysPaediatric patients (3 months to 12 years)Pharyngitis or Tonsillitis: 20 mg/kg/day in two divided doses 5-10 daysAcute otitis media: 30 mg/kg/day in two divided doses 10 daysAcute bacterial maxillary sinusitis: 30 mg/kg/day in two divided doses 10 daysCommunity acquired pneumonia: 30 mg/kg/day in two divided doses 5-10 daysMDR Typhoid fever: 30 mg/kg/day in two divided doses 10-14 daysUncomplicated skin & skin-structure infections: 30 mg/kg/day in two divided doses 10 daysUncomplicated urinary tract infection: 20 mg/kg/day in two divided doses 7-10 daysCefaclav may be administered without regard to meals.Direction for reconstitution of suspension:Shake the bottle well to loosen the powder. Add 35 ml of boiled and cooled water to the dry powder of the bottle. For ease of preparation, add water to the bottle in two proportions. Shake the bottle well after each addition until all the powder is in suspension.Note: The reconstituted suspension must be stored at 2-8 °C temperature and should be used within 7 days after reconstitution. Shake the suspension well before each use. Keep the bottle tightly closed.Side EffectsGenerally Cefuroxime and Clavulanic acid are well tolerated. However, a few side effects like nausea, vomiting, diarrhea, abdominal discomfort or pain may occur. As with other broad-spectrum antibiotics, prolonged administration of Cefuroxime and Clavulanic acid combination may result in overgrowth o..

Tk.18.00/=

  0 отзывов

Cefaclav 250 Tab

Cefaclav 250 Tab

Cefaclav 250 TabDescriptionCefuroxime is one of the bactericidal second generation cephalosporin antibiotics, which is active against a wide range of Gram-positive and Gram-negative susceptible organisms including many beta-lactamase producing strains. It is indicated for the treatment of infections caused by sensitive bacteria.Clavulanic acid has a similar structure to the beta-lactam antibiotics but binds irreversibly to the beta-lactamase enzymes.The presence of clavulanic acid in Cefaclav formulations protects Cefuroxime from degradation by beta-lactamase enzymes and effectively extends the antibacterial spectrum of Cefuroxime to include many bacteria normally resistant to Cefuroxime and other cephalosporins.IndicationsPharyngitis/tonsillitis caused by Streptococcus pyogenesAcute bacterial otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase-producing strains), Moraxella Catarrhalis (including beta-lactamase-producing strains) or Streptococcus pyogenesAcute bacterial maxillary sinusitis caused by Streptococcus pneumoniae or Haemophilus influenzae (non-beta-lactamase-producing strains only)Lower respiratory tract infections including pneumoniae, caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase-producing strains), Klebsiella spp., Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, Escherichia coliAcute bacterial exacerbations of chronic bronchitis and secondary bacterial infections of acute bronchitis caused by Streptococcus penumoniae, Haemophilus influenzae (beta-lactamase negative strains) or Haemophilus parainfluenzae (beta-lactamase negative strains)Skin and Skin-Structure Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, Escherichia coli, Klebsiella spp. and Enterobacter spp.Urinary tract infections caused by Escherichia coli or Klebsiella pneumoniaeBone and Joint Infections caused by Staphylococcus aureus (penicillinase and non-penicillinase producing strains)Gonorrhea: Uncomplicated and disseminated gonococcal infections due to Neisseria gonorrhoeae (penicillinase- and non-penicillinase-producing strains) in both males and femalesEarly Lyme disease (erythema migrans) caused by Borrelia burgdorferiSepticemia caused by Staphylococcus aureus (penicillinase and non-penicillinase producing strains), Streptococcus pneumoniae, Escherichia coli, Haemophilus influenzae (including ampicillin-resistant strains), and Klebsiella spp.Meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including ampicillin resistant strains), Neisseria meningitidis and Staphylococcus aureus (penicillinase and non-penicillinase producing strains)Switch therapy (injectable to oral) after surgery when patient’s condition is improved.Dosage & AdministrationAdolescents & adults:Pharyngitis or Tonsillitis: 250 mg twice daily 5-10 daysAcute bacterial maxillary sinusitis: 250 mg twice daily 10 daysAcute bacterial exacerbation of chronic bronchitis: 250-500 mg twice daily 10 daysSecondary bacterial infections of acute bronchitis: 250-500 mg twice daily 5-10 daysCommunity acquired pneumonia: 250-500 mg twice daily 5-10 daysUncomplicated skin & skin-structure infections: 250-500 mg twice daily 10 daysMDR Typhoid fever: 500 mg twice daily 10-14 daysUncomplicated urinary tract infection: 250 mg twice daily 7-10 daysUncomplicated gonorrhea: 1000 mg single doseLyme disease: 500 mg twice daily 20 daysPaediatric patients (3 months to 12 years)Pharyngitis or Tonsillitis: 20 mg/kg/day in two divided doses 5-10 daysAcute otitis media: 30 mg/kg/day in two divided doses 10 daysAcute bacterial maxillary sinusitis: 30 mg/kg/day in two divided doses 10 daysCommunity acquired pneumonia: 30 mg/kg/day in two divided doses 5-10 daysMDR Typhoid fever: 30 mg/kg/day in two divided doses 10-14 daysUncomplicated skin & skin-structure infections: 30 mg/kg/day in two divided doses 10 daysUncomplicated urinary tract infection: 20 mg/kg/day in two divided doses 7-10 daysCefaclav may be administered without regard to meals.Direction for reconstitution of suspension:Shake the bottle well to loosen the powder. Add 35 ml of boiled and cooled water to the dry powder of the bottle. For ease of preparation, add water to the bottle in two proportions. Shake the bottle well after each addition until all the powder is in suspension.Note: The reconstituted suspension must be stored at 2-8 °C temperature and should be used within 7 days after reconstitution. Shake the suspension well before each use. Keep the bottle tightly closed.Side EffectsGenerally Cefuroxime and Clavulanic acid are well tolerated. However, a few side effects like nausea, vomiting, diarrhea, abdominal discomfort or pain may occur. As with other broad-spectrum antibiotics, prolonged administration of Cefuroxime and Clavulanic acid combination may result in overgrowth o..

Tk.30.00/=

  0 отзывов

Cefaclav 500 Tab

Cefaclav 500 Tab

Cefaclav 500 TabDescriptionCefuroxime is one of the bactericidal second generation cephalosporin antibiotics, which is active against a wide range of Gram-positive and Gram-negative susceptible organisms including many beta-lactamase producing strains. It is indicated for the treatment of infections caused by sensitive bacteria.Clavulanic acid has a similar structure to the beta-lactam antibiotics but binds irreversibly to the beta-lactamase enzymes.The presence of clavulanic acid in Cefaclav formulations protects Cefuroxime from degradation by beta-lactamase enzymes and effectively extends the antibacterial spectrum of Cefuroxime to include many bacteria normally resistant to Cefuroxime and other cephalosporins.IndicationsPharyngitis/tonsillitis caused by Streptococcus pyogenesAcute bacterial otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase-producing strains), Moraxella Catarrhalis (including beta-lactamase-producing strains) or Streptococcus pyogenesAcute bacterial maxillary sinusitis caused by Streptococcus pneumoniae or Haemophilus influenzae (non-beta-lactamase-producing strains only)Lower respiratory tract infections including pneumoniae, caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase-producing strains), Klebsiella spp., Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, Escherichia coliAcute bacterial exacerbations of chronic bronchitis and secondary bacterial infections of acute bronchitis caused by Streptococcus penumoniae, Haemophilus influenzae (beta-lactamase negative strains) or Haemophilus parainfluenzae (beta-lactamase negative strains)Skin and Skin-Structure Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, Escherichia coli, Klebsiella spp. and Enterobacter spp.Urinary tract infections caused by Escherichia coli or Klebsiella pneumoniaeBone and Joint Infections caused by Staphylococcus aureus (penicillinase and non-penicillinase producing strains)Gonorrhea: Uncomplicated and disseminated gonococcal infections due to Neisseria gonorrhoeae (penicillinase- and non-penicillinase-producing strains) in both males and femalesEarly Lyme disease (erythema migrans) caused by Borrelia burgdorferiSepticemia caused by Staphylococcus aureus (penicillinase and non-penicillinase producing strains), Streptococcus pneumoniae, Escherichia coli, Haemophilus influenzae (including ampicillin-resistant strains), and Klebsiella spp.Meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including ampicillin resistant strains), Neisseria meningitidis and Staphylococcus aureus (penicillinase and non-penicillinase producing strains)Switch therapy (injectable to oral) after surgery when patient’s condition is improved.Dosage & AdministrationAdolescents & adults:Pharyngitis or Tonsillitis: 250 mg twice daily 5-10 daysAcute bacterial maxillary sinusitis: 250 mg twice daily 10 daysAcute bacterial exacerbation of chronic bronchitis: 250-500 mg twice daily 10 daysSecondary bacterial infections of acute bronchitis: 250-500 mg twice daily 5-10 daysCommunity acquired pneumonia: 250-500 mg twice daily 5-10 daysUncomplicated skin & skin-structure infections: 250-500 mg twice daily 10 daysMDR Typhoid fever: 500 mg twice daily 10-14 daysUncomplicated urinary tract infection: 250 mg twice daily 7-10 daysUncomplicated gonorrhea: 1000 mg single doseLyme disease: 500 mg twice daily 20 daysPaediatric patients (3 months to 12 years)Pharyngitis or Tonsillitis: 20 mg/kg/day in two divided doses 5-10 daysAcute otitis media: 30 mg/kg/day in two divided doses 10 daysAcute bacterial maxillary sinusitis: 30 mg/kg/day in two divided doses 10 daysCommunity acquired pneumonia: 30 mg/kg/day in two divided doses 5-10 daysMDR Typhoid fever: 30 mg/kg/day in two divided doses 10-14 daysUncomplicated skin & skin-structure infections: 30 mg/kg/day in two divided doses 10 daysUncomplicated urinary tract infection: 20 mg/kg/day in two divided doses 7-10 daysCefaclav may be administered without regard to meals.Direction for reconstitution of suspension:Shake the bottle well to loosen the powder. Add 35 ml of boiled and cooled water to the dry powder of the bottle. For ease of preparation, add water to the bottle in two proportions. Shake the bottle well after each addition until all the powder is in suspension.Note: The reconstituted suspension must be stored at 2-8 °C temperature and should be used within 7 days after reconstitution. Shake the suspension well before each use. Keep the bottle tightly closed.Side EffectsGenerally Cefuroxime and Clavulanic acid are well tolerated. However, a few side effects like nausea, vomiting, diarrhea, abdominal discomfort or pain may occur. As with other broad-spectrum antibiotics, prolonged administration of Cefuroxime and Clavulanic acid combination may result in overgrowth o..

Tk.50.00/=

  0 отзывов

Cefaclav 70 ml Susp.

Cefaclav 70 ml Susp.

Cefaclav 70 ml Susp.DescriptionCefuroxime is one of the bactericidal second generation cephalosporin antibiotics, which is active against a wide range of Gram-positive and Gram-negative susceptible organisms including many beta-lactamase producing strains. It is indicated for the treatment of infections caused by sensitive bacteria.Clavulanic acid has a similar structure to the beta-lactam antibiotics but binds irreversibly to the beta-lactamase enzymes.The presence of clavulanic acid in Cefaclav formulations protects Cefuroxime from degradation by beta-lactamase enzymes and effectively extends the antibacterial spectrum of Cefuroxime to include many bacteria normally resistant to Cefuroxime and other cephalosporins.IndicationsPharyngitis/tonsillitis caused by Streptococcus pyogenesAcute bacterial otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase-producing strains), Moraxella Catarrhalis (including beta-lactamase-producing strains) or Streptococcus pyogenesAcute bacterial maxillary sinusitis caused by Streptococcus pneumoniae or Haemophilus influenzae (non-beta-lactamase-producing strains only)Lower respiratory tract infections including pneumoniae, caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase-producing strains), Klebsiella spp., Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, Escherichia coliAcute bacterial exacerbations of chronic bronchitis and secondary bacterial infections of acute bronchitis caused by Streptococcus penumoniae, Haemophilus influenzae (beta-lactamase negative strains) or Haemophilus parainfluenzae (beta-lactamase negative strains)Skin and Skin-Structure Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, Escherichia coli, Klebsiella spp. and Enterobacter spp.Urinary tract infections caused by Escherichia coli or Klebsiella pneumoniaeBone and Joint Infections caused by Staphylococcus aureus (penicillinase and non-penicillinase producing strains)Gonorrhea: Uncomplicated and disseminated gonococcal infections due to Neisseria gonorrhoeae (penicillinase- and non-penicillinase-producing strains) in both males and femalesEarly Lyme disease (erythema migrans) caused by Borrelia burgdorferiSepticemia caused by Staphylococcus aureus (penicillinase and non-penicillinase producing strains), Streptococcus pneumoniae, Escherichia coli, Haemophilus influenzae (including ampicillin-resistant strains), and Klebsiella spp.Meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including ampicillin resistant strains), Neisseria meningitidis and Staphylococcus aureus (penicillinase and non-penicillinase producing strains)Switch therapy (injectable to oral) after surgery when patient’s condition is improved.Dosage & AdministrationAdolescents & adults:Pharyngitis or Tonsillitis: 250 mg twice daily 5-10 daysAcute bacterial maxillary sinusitis: 250 mg twice daily 10 daysAcute bacterial exacerbation of chronic bronchitis: 250-500 mg twice daily 10 daysSecondary bacterial infections of acute bronchitis: 250-500 mg twice daily 5-10 daysCommunity acquired pneumonia: 250-500 mg twice daily 5-10 daysUncomplicated skin & skin-structure infections: 250-500 mg twice daily 10 daysMDR Typhoid fever: 500 mg twice daily 10-14 daysUncomplicated urinary tract infection: 250 mg twice daily 7-10 daysUncomplicated gonorrhea: 1000 mg single doseLyme disease: 500 mg twice daily 20 daysPaediatric patients (3 months to 12 years)Pharyngitis or Tonsillitis: 20 mg/kg/day in two divided doses 5-10 daysAcute otitis media: 30 mg/kg/day in two divided doses 10 daysAcute bacterial maxillary sinusitis: 30 mg/kg/day in two divided doses 10 daysCommunity acquired pneumonia: 30 mg/kg/day in two divided doses 5-10 daysMDR Typhoid fever: 30 mg/kg/day in two divided doses 10-14 daysUncomplicated skin & skin-structure infections: 30 mg/kg/day in two divided doses 10 daysUncomplicated urinary tract infection: 20 mg/kg/day in two divided doses 7-10 daysCefaclav may be administered without regard to meals.Direction for reconstitution of suspension:Shake the bottle well to loosen the powder. Add 35 ml of boiled and cooled water to the dry powder of the bottle. For ease of preparation, add water to the bottle in two proportions. Shake the bottle well after each addition until all the powder is in suspension.Note: The reconstituted suspension must be stored at 2-8 °C temperature and should be used within 7 days after reconstitution. Shake the suspension well before each use. Keep the bottle tightly closed.Side EffectsGenerally Cefuroxime and Clavulanic acid are well tolerated. However, a few side effects like nausea, vomiting, diarrhea, abdominal discomfort or pain may occur. As with other broad-spectrum antibiotics, prolonged administration of Cefuroxime and Clavulanic acid combination may result in overgrow..

Tk.250.00/=

  0 отзывов

Cefazid 1g IV/IM

Cefazid 1g IV/IM

Cefazid 1g IV/IM..

Tk.240.00/=

  0 отзывов

Cefazid 250 mg IV/IM

Cefazid 250 mg IV/IM

Cefazid 250 mg IV/IM..

Tk.85.00/=

  0 отзывов

Cefazid 500 mg IV/IM

Cefazid 500 mg IV/IM

Cefazid 500 mg IV/IM..

Tk.130.00/=

  0 отзывов

Cefobac 250

Cefobac 250

Cefobac 250..

Tk.25.09/=

  0 отзывов

Cefobac 500 Tab

Cefobac 500 Tab

Cefobac 500 Tab..

Tk.45.12/=

  0 отзывов

Cefobac 70 ml

Cefobac 70 ml

Cefobac 70 ml..

Tk.198.75/=

  0 отзывов

Cefotil 250 mg Tablet

Cefotil 250 mg Tablet

Cefotil 250 mg TabletIndication:Cefotil TM (Cefuroxime) is indicated in the treatment of:1. Upper respiratory tract infections: for example, ear, nose and throat infections such asotitis media, sinusitis, tonsillitis and pharyngitis.2. Lower respiratory tract infections: for example, acute bronchitis, acute exacerbations ofchronic bronchitis and pneumonia.3. Skin and soft tissue infections: such as furunculosis, pyoderma, and impetigo.4. Genito-urinary tract infections: such as pyelonephritis, urethritis, and cystitis.5. Gonorrhoea: acute uncomplicated gonococcal urethritis, and cervicitis.6. Early Lyme disease & subsequent prevention of late Lyme disease.Dosage & Administration:Adults: Most infections will respond to 250 mg b.i.d. In mild to moderate lower respiratorytract infections e.g. bronchitis 250 mg b.i.d. should be given. For more severe lowerrespiratory tract infections, or if pneumonia is suspected then 500 mg b.i.d. should begiven.For urinary tract infections a dose of 125 mg b.i.d. is usually adequate; in pyelonephritisthe recommended dose is 250 mg b.i.d.A single dose of one gram is recommended for the treatment of uncomplicatedgonorrhoea.Lyme disease in adults and children over the age of 12 years: the recommended dose is500 mg b.i.d. for 20 days.Children: The usual dose is 125 mg b.i.d., or 10 mg/kg b.i.d. to a maximum of 250 mgdaily.For otitis media, in children less than 2 years of age the usual dosage is 125 mg b.i.d., or10 mg/kg b.i.d. to a maximum of 250 mg daily and in children over 2 years of age, 250 mgb.i.d., or 15 mg/kg b.i.d. to a maximum of 500 mg daily.There is no experience in children under three months of age. The usual course of therapyis seven days. Cefuroxime should be taken after food for optimum absorption...

Tk.25.17/=

  0 отзывов

Cefotil 500 mg Tablet

Cefotil 500 mg Tablet

Cefotil 500 mg TabletIndication:Cefotil TM (Cefuroxime) is indicated in the treatment of:1. Upper respiratory tract infections: for example, ear, nose and throat infections such asotitis media, sinusitis, tonsillitis and pharyngitis.2. Lower respiratory tract infections: for example, acute bronchitis, acute exacerbations ofchronic bronchitis and pneumonia.3. Skin and soft tissue infections: such as furunculosis, pyoderma, and impetigo.4. Genito-urinary tract infections: such as pyelonephritis, urethritis, and cystitis.5. Gonorrhoea: acute uncomplicated gonococcal urethritis, and cervicitis.6. Early Lyme disease & subsequent prevention of late Lyme disease.Dosage & Administration:Adults: Most infections will respond to 250 mg b.i.d. In mild to moderate lower respiratorytract infections e.g. bronchitis 250 mg b.i.d. should be given. For more severe lowerrespiratory tract infections, or if pneumonia is suspected then 500 mg b.i.d. should begiven.For urinary tract infections a dose of 125 mg b.i.d. is usually adequate; in pyelonephritisthe recommended dose is 250 mg b.i.d.A single dose of one gram is recommended for the treatment of uncomplicatedgonorrhoea.Lyme disease in adults and children over the age of 12 years: the recommended dose is500 mg b.i.d. for 20 days.Children: The usual dose is 125 mg b.i.d., or 10 mg/kg b.i.d. to a maximum of 250 mgdaily.For otitis media, in children less than 2 years of age the usual dosage is 125 mg b.i.d., or10 mg/kg b.i.d. to a maximum of 250 mg daily and in children over 2 years of age, 250 mgb.i.d., or 15 mg/kg b.i.d. to a maximum of 500 mg daily.There is no experience in children under three months of age. The usual course of therapyis seven days. Cefuroxime should be taken after food for optimum absorption...

Tk.45.29/=

  0 отзывов

Cefotil Plus 250 Tablet

Cefotil Plus 250 Tablet

Cefotil Plus 250Indication:Infections caused by susceptible microorganisms including Respiratory Tract Infections, Urinary Tract Infections, Skin and Soft Tissue Infections etc.Dosage & Administration:Usual dose (Adults): 01 Tablet 02 times daily for 7-10 daysUsual dose (Children from 3 months to 12 years): 20-30 mg/kg/day 02 times daily for 7-10 days.Preparation:Cefotil™ Plus 500 Tablet: Each box contains 12 tablets in blister pack.Cefotil™ Plus 250 Tablet: Each box contains 10 tablets in blister pack.Cefotil™ Plus PFS : Bottle containing dry powder to reconstitute 70 ml suspension...

Tk.30.10/=

  0 отзывов

Cefotil Plus 500 Tablet

Cefotil Plus 500 Tablet

Cefotil Plus 500 tabIndication:Infections caused by susceptible microorganisms including Respiratory Tract Infections, Urinary Tract Infections, Skin and Soft Tissue Infections etc.Dosage & Administration:Usual dose (Adults): 01 Tablet 02 times daily for 7-10 daysUsual dose (Children from 3 months to 12 years): 20-30 mg/kg/day 02 times daily for 7-10 days.Preparation:Cefotil™ Plus 500 Tablet: Each box contains 12 tablets in blister pack.Cefotil™ Plus 250 Tablet: Each box contains 10 tablets in blister pack.Cefotil™ Plus PFS : Bottle containing dry powder to reconstitute 70 ml suspension...

Tk.50.15/=

  0 отзывов

Cefotil Plus Suspension 70ml bottle

Cefotil Plus Suspension 70ml bottle

Indication:Infections caused by susceptible microorganisms including Respiratory Tract Infections, Urinary Tract Infections, Skin and Soft Tissue Infections etc.Dosage & Administration:Usual dose (Adults): 01 Tablet 02 times daily for 7-10 daysUsual dose (Children from 3 months to 12 years): 20-30 mg/kg/day 02 times daily for 7-10 days.Preparation:Cefotil™ Plus 500 Tablet: Each box contains 12 tablets in blister pack.Cefotil™ Plus 250 Tablet: Each box contains 10 tablets in blister pack.Cefotil™ Plus PFS : Bottle containing dry powder to reconstitute 70 ml suspension...

Tk.250.00/=

  0 отзывов

Cefotil Suspension 70 ml bottle

Cefotil Suspension 70 ml bottle

Cefotil PFS 70 mlIndication:Cefotil TM (Cefuroxime) is indicated in the treatment of:1. Upper respiratory tract infections: for example, ear, nose and throat infections such asotitis media, sinusitis, tonsillitis and pharyngitis.2. Lower respiratory tract infections: for example, acute bronchitis, acute exacerbations ofchronic bronchitis and pneumonia.3. Skin and soft tissue infections: such as furunculosis, pyoderma, and impetigo.4. Genito-urinary tract infections: such as pyelonephritis, urethritis, and cystitis.5. Gonorrhoea: acute uncomplicated gonococcal urethritis, and cervicitis.6. Early Lyme disease & subsequent prevention of late Lyme disease.Dosage & Administration:Adults: Most infections will respond to 250 mg b.i.d. In mild to moderate lower respiratorytract infections e.g. bronchitis 250 mg b.i.d. should be given. For more severe lowerrespiratory tract infections, or if pneumonia is suspected then 500 mg b.i.d. should begiven.For urinary tract infections a dose of 125 mg b.i.d. is usually adequate; in pyelonephritisthe recommended dose is 250 mg b.i.d.A single dose of one gram is recommended for the treatment of uncomplicatedgonorrhoea.Lyme disease in adults and children over the age of 12 years: the recommended dose is500 mg b.i.d. for 20 days.Children: The usual dose is 125 mg b.i.d., or 10 mg/kg b.i.d. to a maximum of 250 mgdaily.For otitis media, in children less than 2 years of age the usual dosage is 125 mg b.i.d., or10 mg/kg b.i.d. to a maximum of 250 mg daily and in children over 2 years of age, 250 mgb.i.d., or 15 mg/kg b.i.d. to a maximum of 500 mg daily.There is no experience in children under three months of age. The usual course of therapyis seven days. Cefuroxime should be taken after food for optimum absorption...

Tk.199.34/=

  0 отзывов

Celofen 100 mg Tablet

Celofen 100 mg Tablet

Celofen Tab..

Tk.4.01/=

  0 отзывов

Cenolon Inj.

Cenolon Inj.

Cenolon Inj.DescriptionTriamcinolone Acetonide is a synthetic corticosteroid having glucocorticoid activity with marked anti-inflammatory action. Triamcinolone Acetonide has an extended duration of effect which may be permanent, or sustained over a period of several weeks.IndicationsPost-traumatic osteoarthritis, synovitis of osteoarthritis, rheumatoid arthritis, acute and sub-acute bursitis, epicondylitis, acute non-specific tenosynovitis, acute gouty arthritis, psoriatic arthritis, ankylosing spondylitis, juvenile rheumatoid arthritis, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome), exfoliative dermatitis, bullous dermatitis herpetiformis, severe seborrheic dermatitis, severe psoriasis, bronchial asthma, contact dermatitis, atopic dermatitis, seasonal or perennial allergic rhinitis.Dosage & AdministrationChildren 6 to 12 years: initial dose is 40 mgAdults and children over 12 years of age: initial dose is 60 mg. Dosage is usually adjusted within the range of 40 to 80 mg. For local areas, dose for adults is up to 10 mg for smaller areas and up to 40 mg for larger areas.Side EffectsCushingoid syndrome, weakness, bruising or purpura, aggravation of infections, peptic ulcer, activation of latent or aggravation of existing diabetes, altered menstrual cycle, hirsutism.PrecautionsTriamcinolone Acetonide injection should be used cautiously in patients with ocular herpes simplex, nonspecific ulcerative colitis, active or latent peptic ulcer, renal insufficiency, hypertension, osteoporosis, Cushing's syndrome, diabetes mellitus, congestive heart failure, chronic nephritis.Use in Pregnancy & LactationTriamcinolone Acetonide injection should be used during pregnancy, nursing mothers if the possible benefits of the medication justify the potential hazards to the fetus or nursing infant.Drug InteractionAminoglutethimide: Aminoglutethimide may lead to a loss of corticosteroid-induced adrenal suppression.Amphotericin B injection and potassium-depleting agents: When corticosteroids are administered concomitantly with potassium-depleting agents (ie, amphotericin B, diuretics), patients should be observed closely for development of hypokalemia. There have been cases reported in which concomitant use of amphotericin B and hydrocortisone was followed by cardiac enlargement and congestive heart failure.Antibiotics: Macrolide antibiotics have been reported to cause a significant decrease in corticosteroid clearance.Anticholinesterases: Concomitant use of anticholinesterase agents and corticosteroids may produce severe weakness in patients with myasthenia gravis. If possible, anticholinesterase agents should be withdrawn at least 24 hours before initiating corticosteroid therapy.Anticoagulants, oral: Coadministration of corticosteroids and warfarin usually results in inhibition of response to warfarin, although there have been some conflicting reports. Therefore, coagulation indices should be monitored frequently to maintain the desired anticoagulant effect.Antidiabetics: Because corticosteroids may increase blood glucose concentrations, dosage adjustments of antidiabetic agents may be required.Antitubercular drugs: Serum concentrations of isoniazid may be decreased.Cholestyramine: Cholestyramine may increase the clearance of corticosteroids.Cyclosporine: Increased activity of both cyclosporine and corticosteroids may occur when the two are used concurrently. Convulsions have been reported with this concurrent use.Digitalis glycosides: Patients on digitalis glycosides may be at increased risk of arrhythmias due to hypokalemia.Estrogens, including oral contraceptives: Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect.Hepatic enzyme inducers (eg, barbiturates, phenytoin, carbamazepine, rifampin): Drugs which induce hepatic microsomal drug metabolizing enzyme activity may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased.Ketoconazole: Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60%, leading to an increased risk of corticosteroid side effects.Nonsteroidal anti-inflammatory drugs (NSAIDs): Concomitant use of aspirin (or other nonsteroidal anti-inflammatory drugs) and corticosteroids increases the risk of gastrointestinal side effects. Aspirin should be used cautiously in conjunction with corticosteroids in hypoprothrombinemia. The clearance of salicylates may be increased with concurrent use of corticosteroids.Skin tests: Corticosteroids may suppress reactions to skin tests.Vaccines: Patients on prolonged corticosteroid therapy may exhibit a diminished response to toxoids and live or inactivated vaccines due to inhibition of antibody response. Corticosteroids may also potentiate the replication of some organisms contained in live attenuated vaccines. Routine administration of vaccines or toxoids should be deferred until corticosteroid therapy is disc..

Tk.75.00/=

  0 отзывов

Cenolon Nasal Spray

Cenolon Nasal Spray

Cenolon Nasal SprayDescriptionTriamcinolone Acetonide is a corticosteroid. It is a more potent derivative of Triamcinolone and approximately 8 times more potent than Prednisone. Although the precise mechanism of corticosteroid antiallergic action is unknown, corticosteroids are very effective.IndicationsCenolon Nasal Spray is indicated for the treatment of the nasal symptoms of seasonal and perennial allergic rhinitis in adults and children 2 years of age and older.Dosage & AdministrationAdults and children 12 years of age and older: The recommended starting and maximum dose is 220 mcg per day as two sprays in each nostril once daily.Children 2 to 12 years of age: The recommended starting dose is 110 mcg per day given as one spray in each nostril once daily. The maximum recommended dose is 220 mcg per day as two sprays per nostril once daily.Side EffectsGenerally, Triamcinolone Acetonide, is well tolerated. However, few side-effects such as-pharyngitis, epistaxis, increase in cough, headache, infection, sinusitis and vomiting may occur.PrecautionsTriamcinolone Acetonide nasal spray should be used with caution, if at all, in patients with active or quiescent tuberculous infection of the respiratory tract or in patients with untreated fungal, bacterial, or systemic viral infections or ocular herpes simplex. In clinical studies with Triamcinolone Acetonide nasal spray, the development of localized infections of the nose and pharynx with Candida albicans has rarely occurred.Use in Pregnancy & LactationPregnancy: There are no adequate and well-controlled studies in pregnant women. Triamcinolone Acetonide nasal spray, like other corticosteroids, should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.Lactation: It is not known whether Triamcinolone Acetonide is excreted in human milk. Because other corticosteroids are excreted in human milk, caution should be exercised when Triamcinolone Acetonide nasal spray is administered to nursing women.Over DoseLike any other nasally administered corticosteroids, acute overdosing is unlikely in view of the total amount of active ingredient present. In the event that the entire contents of the bottle were administered all at once, via either oral or nasal application, clinically significant systemic adverse events would most likely not result. The patient may experience some gastrointestinal upseCommercial PackCenolon Nasal Spray: Each bottle contains 120 metered dose spray...

Tk.200.00/=

  0 отзывов

Cerox A 250 Tab

Cerox A 250 Tab

Cerox A 250 Tab..

Tk.25.17/=

  0 отзывов

Cerox A 500 Tab

Cerox A 500 Tab

Cerox A 500 Tab..

Tk.45.31/=

  0 отзывов

Cerox A Suspen 70 ml

Cerox A Suspen 70 ml

Cerox A Suspen 70 ml..

Tk.199.35/=

  0 отзывов

Cerox CV 125

Cerox CV 125

Cerox CV 125..

Tk.21.06/=

  0 отзывов

Cerox CV 250 Tab

Cerox CV 250 Tab

Cerox CV 250 Tab..

Tk.32.09/=

  0 отзывов

cerox-cv-500mg

Cerox CV 500 Tab

Cerox CV 500 Tab..

Tk.52.00/=

  0 отзывов

Cerox CV 70ml Susp

Cerox CV 70ml Susp

Cerox CV 70ml Susp..

Tk.250.75/=

  0 отзывов

Cerox-A IV Inj

Cerox-A IV Inj

Cerox-A IV Inj..

Tk.55.38/=

  0 отзывов

Cetizin Tablet

Cetizin Tablet

Cetizin..

Tk.3.01/=

  0 отзывов

Cinarex-D Ophthalmic suspension

Cinarex-D Ophthalmic suspension

...to fight infections and inflammations togetherDexamethasone is glucocorticoid. It has an anti-inflammatory and anti-allergic action. It is used topically in the treatment of inflammatory conditions of the anterior segment of the eye. The efficacy of corticosteroids for the treatment of inflammatory conditions of the eye is well established. It works by reducing swelling. Tobramycin is an aminoglycoside antibiotic for topical administration to the eyes. It works by stopping the growth of bacteria by inhibiting protein synthesis. Tobramycin provide antibacterial protection against susceptible becteria.This combination eye drop is indicated for reduction of inflammation and prophylaxis of infection following cataract surgery.Cinarex®-D Ophthalmic suspension: Plastic dropper bottle contains 5 ml sterile suspension. Each ml contains Dexamethasone USP 1 mg and Tobramycin USP 3 mg.Ensures effective relief from inflammation after ocular surgeryEnsures comfort to the patientsSafe and well toleratedMost suitable for blepharo-keratoconjunctivitis..

Tk.150.00/=

  0 отзывов

Citin 10 mg tab

Citin 10 mg tab

Citin 10 mg tab..

Tk.3.00/=

  0 отзывов

Citin Syrup

Citin Syrup

Citin..

Tk.30.10/=

  0 отзывов

Clavurox 500

Clavurox 500

Clavurox 500..

Tk.50.00/=

  0 отзывов

Clavurox PFS 70ml

Clavurox PFS 70ml

Clavurox PFS 70ml..

Tk.252.00/=

  0 отзывов

Clavusef 125mg Tab

Clavusef 125mg Tab

Clavusef 125..

Tk.18.04/=

  0 отзывов

Clavusef 250 mg tab

Clavusef 250 mg tab

Clavusef 250 mg tab..

Tk.30.10/=

  0 отзывов

Clavusef 500 mg tab

Clavusef 500 mg tab

Clavusef 500 mg tab..

Tk.50.15/=

  0 отзывов

Clavusef 70 ml Susp.

Clavusef 70 ml Susp.

Clavusef 70 ml Susp...

Tk.252.75/=

  0 отзывов

Clindax-B Gel

Clindax-B Gel

Clindax-B Gel..

Tk.150.45/=

  0 отзывов

Clindax-B Topical Gel

Clindax-B Topical Gel

Clindax-B Topical Gel..

Tk.150.00/=

  0 отзывов

Clinorel 200 mg tab

Clinorel 200 mg tab

Clinorel 200 mg tab..

Tk.9.56/=

  0 отзывов

Clobesol Cream

Clobesol Cream

Clobesol has both local anti-inflammatory and immunosuppressive activity. The drug blocks the effect of macrophage migration inhibitory factor and decreases the activation of plasminogen to plasmin. Clobesol also reduces the number of human leukocyte antigen & also inhibits phospholipase A2 activity via formation of lipocortin. Clobetasol reduces the formation of prostaglandins and leucotrienes in the local tissues...

Tk.58.00/=

  0 отзывов

Showing 351 to 400 of 2023 (41 Pages)